glp-1 news today october 16 2025 Receptor Agonist Market Size & Trends 2035 A North Carolina woman was

7g of fiber and 14g of protein per serving*

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a randomized trial showed.Among 407 adults, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score from baseline to week 68 was -41.7 points in the semaglutide group and -27.5 points in the placebo group (P

Heart palpitations during semaglutide treatment are a real concern for some patients

GLP-1s have much more long term safety data although have the undesirable side effect of sarcopenia (loss of muscle mass)

A unique formula that promotes digestive comfort to help ease GLP-1 side effects

Deal Snapshot: Novo is partnering with Ascendis on less frequently dosed drugs for metabolic diseases, committing up to $285m for a lead program, a once-monthly GLP-1 receptor agonist.